MCM
IONS icon

MAI Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

MAI Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$70.6K Buy
940
+40
+4% +$3.16K ﹤0.01% 2025
2025
Q4 		$71.2K Buy
900
+633
+237% +$47.7K ﹤0.01% 1818
2025
Q3 		$17.5K Sell
267
-159
-37% -$7.76K ﹤0.01% 2466
2025
Q2 		$16.8K Buy
426
+166
+64% +$5.43K ﹤0.01% 2440
2025
Q1 		$7.84K Hold
260
– – ﹤0.01% 2581
2024
Q4 		$9.09K Buy
+260
New +$9.72K ﹤0.01% 2550

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MAI Capital Management's IONS Position: Q1 2026 in Review

MAI Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 4.4% in Q1 2026, buying an estimated $3.16K and bringing the position to 940 shares worth $70.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2025.

MAI Capital Management first reported a position in IONS in Q4 2024 and has held it in 6 quarters since. The position peaked at $71.2K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • MAI Capital Management held 940 shares of Ionis Pharmaceuticals worth $70.6K as of Q1 2026.
  • MAI Capital Management bought 40 Ionis Pharmaceuticals shares in Q1 2026, an estimated $3.16K.
  • Ionis Pharmaceuticals made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #2025 holding.
  • MAI Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's Ionis Pharmaceuticals position peaked at $71.2K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.